Shouvik Dass

1.5k total citations
36 papers, 1.1k citations indexed

About

Shouvik Dass is a scholar working on Rheumatology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shouvik Dass has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 13 papers in Genetics and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shouvik Dass's work include Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Shouvik Dass is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Shouvik Dass collaborates with scholars based in United Kingdom, Israel and Italy. Shouvik Dass's co-authors include Paul Emery, Edward M Vital, Andy C. Rawstron, Karen Henshaw, Md Yuzaiful Md Yusof, Maya H Buch, Dennis McGonagle, Paul Beirne, Michael F. Martin and Colin Pease and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Shouvik Dass

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shouvik Dass United Kingdom 13 568 487 262 227 220 36 1.1k
Md Yuzaiful Md Yusof United Kingdom 17 700 1.2× 535 1.1× 194 0.7× 118 0.5× 247 1.1× 65 1.2k
Stefania Sacco Italy 13 502 0.9× 264 0.5× 144 0.5× 211 0.9× 134 0.6× 20 958
Stella Burns United Kingdom 5 275 0.5× 327 0.7× 108 0.4× 242 1.1× 118 0.5× 7 714
J Sánchez-Román Spain 18 361 0.6× 322 0.7× 105 0.4× 64 0.3× 164 0.7× 34 869
Laura Nuño Spain 16 562 1.0× 478 1.0× 209 0.8× 114 0.5× 56 0.3× 60 944
Felicia Anna Tucci Italy 15 378 0.7× 194 0.4× 73 0.3× 287 1.3× 125 0.6× 24 1.1k
Kristján Steinsson Iceland 13 695 1.2× 751 1.5× 141 0.5× 72 0.3× 70 0.3× 17 1.1k
Petra Roll Germany 13 285 0.5× 380 0.8× 215 0.8× 165 0.7× 145 0.7× 19 735
Noriyuki Kurata Japan 10 301 0.5× 146 0.3× 186 0.7× 64 0.3× 194 0.9× 27 650
Tom J. G. Swaak Netherlands 20 821 1.4× 451 0.9× 338 1.3× 54 0.2× 111 0.5× 26 1.1k

Countries citing papers authored by Shouvik Dass

Since Specialization
Citations

This map shows the geographic impact of Shouvik Dass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shouvik Dass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shouvik Dass more than expected).

Fields of papers citing papers by Shouvik Dass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shouvik Dass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shouvik Dass. The network helps show where Shouvik Dass may publish in the future.

Co-authorship network of co-authors of Shouvik Dass

This figure shows the co-authorship network connecting the top 25 collaborators of Shouvik Dass. A scholar is included among the top collaborators of Shouvik Dass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shouvik Dass. Shouvik Dass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fitton, John, Andrew Melville, Andrea Di Matteo, et al.. (2025). Neither ultrasound synovitis nor clinical-ultrasound phenotypes of established rheumatoid arthritis predict response to targeted therapy. Lara D. Veeken. 64(12). 6079–6089.
2.
Matteo, Andrea Di, Paula David, Shouvik Dass, et al.. (2025). Predicting rapid radiographic progression in difficult-to-treat rheumatoid arthritis: insights from long-term follow-up. Lara D. Veeken. 65(1).
3.
Matteo, Andrea Di, et al.. (2025). Remission is the ambition: can remission rates for new patients with rheumatoid arthritis finally be improved, at minimal cost?. Lara D. Veeken. 64(7). 4107–4109. 1 indexed citations
4.
David, Paula, Tom Macleod, Yu Shi, et al.. (2025). Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritis. Annals of the Rheumatic Diseases. 85(1). 114–127.
5.
Carter, L. M., et al.. (2024). ANA-associated arthritis: clinical and biomarker characterization of a population for basket trials. Lara D. Veeken. 63(11). 3135–3145.
6.
David, Paula, Andrea Di Matteo, Shouvik Dass, et al.. (2023). Poly‐Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes. Arthritis & Rheumatology. 76(4). 510–521. 21 indexed citations
7.
Vital, Edward M, Shouvik Dass, Aamir Aslam, et al.. (2022). A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis. Frontiers in Immunology. 12. 803175–803175. 12 indexed citations
8.
Dass, Shouvik, Sarah Twigg, C. H. Jones, et al.. (2022). Efficacy and safety of obinutuzumab in systemic lupus erythematosus patients with secondary non-response to rituximab. Lara D. Veeken. 61(12). 4905–4909. 36 indexed citations
9.
Vital, Edward M, Andy C. Rawstron, Colin Pease, et al.. (2022). P245 Identifying predictors of short-term response to rituximab in extra-glandular primary Sjogren’s Syndrome. Lara D. Veeken. 61(Supplement_1). 1 indexed citations
10.
Rajeswaran, Thurkka, Andrew Barr, Aruna Chakrabarty, et al.. (2022). OA42 Evaluating the effects on a clinical service of introducing ultrasound for diagnosis of giant cell arteritis using Lean methodology. Lara D. Veeken. 61(Supplement_1).
11.
12.
Marzo‐Ortega, Helena, et al.. (2020). Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic. The Lancet Rheumatology. 2(7). e386–e387. 2 indexed citations
13.
Fitton, John, Andrew Melville, Shouvik Dass, et al.. (2019). THU0169 JANUS KINASE INHIBITORSDEMONSTRATE EFFECTIVENESS IN A REAL-WORLD MULTI-BIOLOGIC DMARD REFRACTORY RHEUMATOID ARTHRITIS POPULATION. Annals of the Rheumatic Diseases. 78. 358–359. 2 indexed citations
14.
Yusof, Md Yuzaiful Md, Edward M Vital, Sudipto Das, et al.. (2015). Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions. Annals of the Rheumatic Diseases. 74(9). 1734–1738. 29 indexed citations
15.
Vital, Edward M, Shouvik Dass, Maya H Buch, Andy C. Rawstron, & Paul Emery. (2014). An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial. Annals of the Rheumatic Diseases. 74(6). 1195–1201. 42 indexed citations
16.
Vital, Edward M, Shouvik Dass, Maya H Buch, et al.. (2011). B cell biomarkers of rituximab responses in systemic lupus erythematosus. Arthritis & Rheumatism. 63(10). 3038–3047. 177 indexed citations
17.
Vital, Edward M, Andy C. Rawstron, Shouvik Dass, et al.. (2010). Reduced-dose rituximab in rheumatoid arthritis: Efficacy depends on degree of B cell depletion. Arthritis & Rheumatism. 63(3). 603–608. 65 indexed citations
18.
Dass, Shouvik, Andy C. Rawstron, Edward M Vital, et al.. (2008). Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis. Arthritis & Rheumatism. 58(10). 2993–2999. 166 indexed citations
19.
Dass, Shouvik, Edward M Vital, & Paul Emery. (2007). Development of psoriasis after B cell depletion with rituximab. Arthritis & Rheumatism. 56(8). 2715–2718. 181 indexed citations
20.
Dass, Shouvik, Edward M Vital, & Paul Emery. (2006). Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis. Expert Opinion on Pharmacotherapy. 7(18). 2559–2570. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Md Yuzaiful Md Yusof Breakdown of academic impact, for papers by Stefania Sacco Breakdown of academic impact, for papers by Stella Burns Breakdown of academic impact, for papers by J Sánchez-Román Breakdown of academic impact, for papers by Laura Nuño Breakdown of academic impact, for papers by Felicia Anna Tucci Breakdown of academic impact, for papers by Kristján Steinsson Breakdown of academic impact, for papers by Petra Roll Breakdown of academic impact, for papers by Noriyuki Kurata Breakdown of academic impact, for papers by Tom J. G. Swaak
Rankless by CCL
2026